Back
Inogen, Inc. 10K Form
Buy
52
INGN
Inogen, Inc.
Last Price:
$7.07
Seasonality Move:
-5.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | INGN/Inogen, Inc. Quarterly |
| 2023-11-09 | 10Q | INGN/Inogen, Inc. Quarterly |
| 2023-08-08 | 10Q | INGN/Inogen, Inc. Quarterly |
| 2023-05-05 | 10Q | INGN/Inogen, Inc. Quarterly |
| 2022-11-03 | 10Q | INGN/Inogen, Inc. Quarterly |
| 2022-08-04 | 10Q | INGN/Inogen, Inc. Quarterly |
Receive INGN News And Ratings
See the #1 stock for the next 7 days that we like better than INGN
INGN Financial Statistics
Sales & Book Value
| Annual Sales: | $335.7M |
|---|---|
| Cash Flow: | $64K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.26 |
| Price / Book: | 0.97 |
Profitability
| EPS (TTM): | -1.00410 |
|---|---|
| Net Income (TTM): | $-25.4M |
| Gross Margin: | $162.5M |
| Return on Equity: | -13.3% |
| Return on Assets: | -8.29% |
Inogen, Inc. Earnings Forecast
Key Inogen, Inc. Financial Ratios
-
The Gross Profit Margin over the past 21 years for INGN is 48.40%.
-
The Selling, General & Administrative Expenses for INGN have been equal to 52.32% of Gross Profit Margin.
-
The Research & Development expenses have been 6.37% of Revenue.
-
The Net Earning history of INGN is -10.69% of Total Revenues.
-
Per Share Earnings over the last 21 years have been positive in 11 years.
Inogen, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | INGN |
| CUSIP: | 45780L |
| Website: | inogen.com |
Debt
| Debt-to-Equity Ratio: | 0.09 |
|---|---|
| Current Ratio: | 3.14 |
| Quick Ratio: | 2.54 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INGN Technical Analysis vs Fundamental Analysis
Buy
52
Inogen, Inc. (INGN)
is a Buy
Is Inogen, Inc. a Buy or a Sell?
-
Inogen, Inc. stock is rated a BuyThe current Inogen, Inc. [INGN] share price is $7.06. The Score for INGN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.